1.02 (-%)
As of Nov 01, 2024
Source:
RenovoRxis a clinical-stage biopharmaceutical company with a vision to disrupt the current paradigm of cancer treatment. Our mission is tolead a revolution in oncology therapy by delivering its innovative and targeted intra-arterial (IA) delivery of chemotherapydirectly to solid tumors.
Country | United States |
Headquarters | san jose, california |
Phone Number | 408-800-2649 |
Industry | |
CEO | Shaun R. Bagai |
Website | www.renovorx.com |